Next Article in Journal
Testing Adaptive Therapy Protocols Using Gemcitabine and Capecitabine in a Preclinical Model of Endocrine-Resistant Breast Cancer
Previous Article in Journal
Second-Line Treatment Options for Small-Cell Lung Cancer: A Light at the End of the Tunnel
Previous Article in Special Issue
BR109, a Novel Fully Humanized T-Cell-Engaging Bispecific Antibody with GPRC5D Binding, Has Potent Antitumor Activities in Multiple Myeloma
 
 
Review

Article Versions Notes

Cancers 2024, 16(2), 256; https://doi.org/10.3390/cancers16020256
Action Date Notes Link
article xml file uploaded 6 January 2024 08:37 CET Original file -
article xml uploaded. 6 January 2024 08:37 CET Update https://www.mdpi.com/2072-6694/16/2/256/xml
article pdf uploaded. 6 January 2024 08:37 CET Version of Record https://www.mdpi.com/2072-6694/16/2/256/pdf
article html file updated 6 January 2024 08:39 CET Original file https://www.mdpi.com/2072-6694/16/2/256/html
Back to TopTop